Financial News
All News about Immunogen Inc
![](https://mms.businesswire.com/media/20220103005412/en/1317123/5/imgnlogo.jpg)
From ImmunoGen Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20211229005002/en/1314584/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20211212005040/en/935398/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20211206005791/en/933420/5/imgnlogo.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/laboratory-g91232d1d0_1920.jpg)
![](https://mms.businesswire.com/media/20211201006279/en/932412/5/imgnlogo.jpg)
ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock
December 02, 2021
From ImmunoGen Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_341.png)
61 Biggest Movers From Yesterday
December 02, 2021
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_3568.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_69.jpg)
50 Stocks Moving In Wednesday's Mid-Day Session
December 01, 2021
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/nerve-cell-2213009_1920_36.jpg)
Via Benzinga
Topics
Intellectual Property
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/price_targets_328.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/peek_into_the_marketnew_314.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_5242.jpeg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_5263.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_340.png)
![](https://g.foolcdn.com/editorial/images/655310/medical-researchers-gettyimages-1213006106.jpg)
![](https://mms.businesswire.com/media/20211130006063/en/931610/5/imgnlogo.jpg)
ImmunoGen Announces Proposed Public Offering of Common Stock
November 30, 2021
From ImmunoGen Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-afternoon-market-update_77.jpg)
![](https://g.foolcdn.com/editorial/images/655262/biotech-gettyimages-1215565992.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day-market-update_77.jpg)
Mid-Day Market Update: Barnes & Noble Education Drops Following Q2 Results; Cumberland Pharmaceuticals Shares Jump
November 30, 2021
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_68.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2655.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/corona-5174671_1920_1_10.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_5197.jpeg)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://mms.businesswire.com/media/20211130005310/en/931177/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20211117005358/en/928041/5/imgnlogo.jpg)
ImmunoGen Appoints Tracey L. McCain, Esq. to Its Board of Directors
November 17, 2021
From ImmunoGen Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20211116006082/en/927756/5/imgnlogo.jpg)
From ImmunoGen Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.